Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal MelanomaC. Mignard, P. Joly, Aurélie Deschamps Huvier et al.|Journal of Oncology|2018Cited by 82
Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre studyHenri Montaudié, Frédéric Peyrade, Andrea Stefan et al.|Oncotarget|2020Cited by 56
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case–control studyLéo Plaçais, Célèste Lebbé, Stéphane Dalle et al.|Annals of the Rheumatic Diseases|2022Cited by 34
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data☆Y. Di Filippo, Henri Montaudié, Stéphane Dalle et al.|Annals of Oncology|2020Cited by 30
New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New ‘Eye-Sparing’ Paradigm?Arnaud Martel, Stéphanie Baillif, Sandra Lassalle et al.|Cancers|2021Cited by 20